Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study

D Aschieri, M Stabile, C Maestri… - Emergency Care …, 2021 - pagepressjournals.org
Hypercoagulability is a common complication of the systemic inflammation related to
coronavirus disease 2019 creating debate within the critical care community on the …
被引用次数：2 相关文章

Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study.

D Aschieri, M Stabile, C Maestri… - Emergency Care …, 2021 - search.ebscohost.com
Hypercoagulability is a common complication of the systemic inflammation related to
coronavirus disease 2019 creating debate within the critical care community on the …
[PDF] researchgate.net

[PDF][PDF] Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study

D Aschieri, M Stabile, C Maestri, L Rosato… - Emergency Care …, 2021 - researchgate.net
Hypercoagulability is a common complication of the systemic inflammation related to
coronavirus disease 2019 creating debate within the critical care community on the …

Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study

D Aschieri, M Stabile, C Maestri… - Emergency Care …, 2021 - pagepressjournals.org
Hypercoagulability is a common complication of the systemic inflammation related to
coronavirus disease 2019 creating debate within the critical care community on the …
[PDF] researchgate.net

[PDF][PDF] Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study

D Aschieri, M Stabile, C Maestri, L Rosato… - Emergency Care …, 2021 - researchgate.net
Hypercoagulability is a common complication of the systemic inflammation related to
coronavirus disease 2019 creating debate within the critical care community on the …